130 AACR CANCER PROGRESS REPORT 2016
Condition Generic Name Trade Name
Breast cancer raloxifene Evista
tamoxifen Nolvadex
Cervical, vulvar, human papillomavirus Gardasil
vaginal, and anal cancers quadrivalent vaccine
and dysplasia; genital warts (types 6, 11, 16, and 18)
Cervical, vulvar, human papillomavirus Gardasil 9
vaginal, and anal cancers 9-valent vaccine
and dysplasia; genital warts (types 6, 11, 16, 18,
31, 33, 45, 52, and 58)
Cervical cancer human papillomavirus Cervarix
and cervical dysplasia bivalent vaccine
(types 16 and 18)
Condition Generic Name Trade Name
Actinic keratosis ingenol mebutate Picato
fluorouracil Adricil
diclofenac sodium Voltaren
5-aminolevulinic acid +
photodynamic therapy (pdt)
masoprocol/ Actinex
nordihydroguaiaretic acid
Bladder dysplasia bacillus calmette-guerin/BCG
valrubicin Valstar
Esophageal dysplasia porfimer sodium + Photofrin
photodynamic therapy (PDT)
*adapted from Wu X, Patterson S, Hawk E. Chemoprevention –
History and general principles. Best Practice Research
Clinical Gastroenterology. 2011;25:445-59.
Cancer Risk Reduction
Treatment of Precancerous Conditions
FDA-APPROVED THERAPEUTICS FOR
CANCER RISK REDUCTION OR TREATMENT
OF PRECANCEROUS CONDITIONS*
SUPPLEMENTAL TABLE 1
